News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC
05 Aug 2026
byStephen Padilla
Patients with recurrent low-grade intermediate-risk nonmuscle-invasive bladder cancer (LG-IR-NMIBC) who achieved an initial complete response (CR) to UGN-102 treatment tend to remain event-free 24 months later, according to phase III ENVISION trial.
05 Aug 2026

Resistance training lifts life quality in people with multiple sclerosis
04 Aug 2026
byStephen Padilla
Individuals with multiple sclerosis may benefit from resistance training, which has been shown in a recent study to potentially improve quality of life (QoL), particularly in the domains related to physical and mental health.
04 Aug 2026






